Skip to main content
Erschienen in: Pediatric Nephrology 3/2007

01.03.2007 | Editorial

Chronic kidney disease: common, harmful and treatable—World Kidney Day 2007

verfasst von: Andrew S. Levey, Sharon P. Andreoli, Thomas DuBose, Robert Provenzano, Allan J. Collins

Erschienen in: Pediatric Nephrology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Excerpt

Thursday, March 8, 2007 is World Kidney Day! World Kidney Day was proposed by the International Society of Nephrology (ISN) and International Federation of Kidney Foundations (IFKF) in 2006 to broadcast a message about kidney diseases to the public, government health officials, general physicians, allied health professionals, individuals, and families. It was launched on March 9, 2006, and will be fully inaugurated this year (https://​doi.​org/​www.​worldkidneyday.​org/​). …
Literatur
1.
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39:S1–S266 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39:S1–S266
2.
Zurück zum Zitat Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147CrossRef Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147CrossRef
3.
Zurück zum Zitat Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rosser J, De Aeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100CrossRef Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rosser J, De Aeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100CrossRef
4.
Zurück zum Zitat Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH (2005) Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 16:180–188CrossRef Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH (2005) Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 16:180–188CrossRef
5.
Zurück zum Zitat Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483CrossRef Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483CrossRef
6.
Zurück zum Zitat US Renal Data System. USRDS 2001 Annual Data Report: atlas of end-stage renal disease in the United States (2001) National Institutes of Health, National Institute of diabetes and digestive and kidney diseases, Bethesda. Ref type: report US Renal Data System. USRDS 2001 Annual Data Report: atlas of end-stage renal disease in the United States (2001) National Institutes of Health, National Institute of diabetes and digestive and kidney diseases, Bethesda. Ref type: report
7.
Zurück zum Zitat Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton L, Hamm L, McCullough PA, Kasiske BL, Kelepouris EK, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108:2154–2169CrossRef Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton L, Hamm L, McCullough PA, Kasiske BL, Kelepouris EK, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108:2154–2169CrossRef
8.
Zurück zum Zitat Keith D, Nicholls G, Guillion C (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659–663CrossRef Keith D, Nicholls G, Guillion C (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659–663CrossRef
9.
Zurück zum Zitat Go AS, Chertow G, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and risks of death, cardiovascular events and hospitalizations. N Engl J Med 351:1296–13056CrossRef Go AS, Chertow G, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and risks of death, cardiovascular events and hospitalizations. N Engl J Med 351:1296–13056CrossRef
10.
Zurück zum Zitat Coca SG, Krumholz HM, Garg AX, Parikh CR (2006) Under representation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296:1377–1384CrossRef Coca SG, Krumholz HM, Garg AX, Parikh CR (2006) Under representation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296:1377–1384CrossRef
11.
Zurück zum Zitat Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134:629–636CrossRef Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134:629–636CrossRef
12.
Zurück zum Zitat Solomon SD, Rice MM, Jablonski KA, Jose P, Domanski M, Sabatine M, Gersh BJ, Rouleau J, Pfeffer MA, Braunwald E (2006) Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation 114:26–31CrossRef Solomon SD, Rice MM, Jablonski KA, Jose P, Domanski M, Sabatine M, Gersh BJ, Rouleau J, Pfeffer MA, Braunwald E (2006) Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation 114:26–31CrossRef
13.
Zurück zum Zitat Tonelli M, Moye L, Sacks FM, Kiberd B, Curan G (2003) Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med 138:98–104CrossRef Tonelli M, Moye L, Sacks FM, Kiberd B, Curan G (2003) Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med 138:98–104CrossRef
14.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572CrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572CrossRef
15.
Zurück zum Zitat American Diabetes Association (2006) American Diabetes Association: standards of medical care in diabetes—2006. Diabetes Care 29:S1–S85CrossRef American Diabetes Association (2006) American Diabetes Association: standards of medical care in diabetes—2006. Diabetes Care 29:S1–S85CrossRef
16.
Zurück zum Zitat Brosius FC, Hostetter TH, Kelepouris E, Moore M, Wilson P (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Hypertension 48:751–755CrossRef Brosius FC, Hostetter TH, Kelepouris E, Moore M, Wilson P (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Hypertension 48:751–755CrossRef
17.
Zurück zum Zitat Kimm SY, Obarzanek E (2002) Childhood obesity: a new pandemic of the new millennium. Pediatrics 110:1003–1007CrossRef Kimm SY, Obarzanek E (2002) Childhood obesity: a new pandemic of the new millennium. Pediatrics 110:1003–1007CrossRef
18.
Zurück zum Zitat Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ (1999) Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10:1793–1800PubMed Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ (1999) Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10:1793–1800PubMed
Metadaten
Titel
Chronic kidney disease: common, harmful and treatable—World Kidney Day 2007
verfasst von
Andrew S. Levey
Sharon P. Andreoli
Thomas DuBose
Robert Provenzano
Allan J. Collins
Publikationsdatum
01.03.2007
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 3/2007
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0423-9

Weitere Artikel der Ausgabe 3/2007

Pediatric Nephrology 3/2007 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.